We are live on
!
Find out more
Parallel Advisors Portfolio holdings
AUM
$6.56B
Turnover
11.49%
1-Year Est. Return
32.24%
This Fund
S&P 500
This Quarter
Est. Return
+8.75%
1 Year Est. Return
+32.24%
3 Year Est. Return
+108.68%
5 Year Est. Return
+114.41%
10 Year Est. Return
–
AUM
$3.69B
AUM Growth
+$319M
(+9.5%)
Cap. Flow
+$89M
Cap. Flow
% of AUM
2.41%
Top 10 Holdings %
Top 10 Hldgs %
34.5%
Holding
3,484
New
163
Increased
1,467
Reduced
807
Closed
181
Avg Time Held Equity + Options
4.2
years
Top 10 Avg Time Held Equity + Options
1.9
years
Top 20 Avg Time Held Equity + Options
3
years
Avg Time Held Equity only
4.2
years
Top 10 Avg Time Held Equity only
1.9
years
Top 20 Avg Time Held Equity only
3
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco S&P 500 Equal Weight ETF
RSP
|
+$50.7M |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$21.6M |
| 3 |
Janus Henderson Mortgage-Backed Securities ETF
JMBS
|
+$15.3M |
| 4 |
iShares Core S&P 500 ETF
IVV
|
+$7.94M |
| 5 |
Apple
AAPL
|
+$4.05M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P Total US Stock Market ETF
ITOT
|
+$43.6M |
| 2 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$32.8M |
| 3 |
iShares MSCI Emerging Markets ex China ETF
EMXC
|
+$3.62M |
| 4 |
NVIDIA
NVDA
|
+$1.54M |
| 5 |
Schwab US Dividend Equity ETF
SCHD
|
+$1.39M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 48.78% |
| 2 | Technology | 15.28% |
| 3 | Healthcare | 8.29% |
| 4 | Financials | 6.97% |
| 5 | Communication Services | 4.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
NVTA
3226
DELISTED
Invitae Corporation
NVTA
| $46 | ﹤0.01% |
4,168
-1,000
| -19% | -$455 |
2019 Q2
19 quarters
|
|
3227
Corvus Pharmaceuticals
CRVS
$809M
| $36 | ﹤0.01% |
20
| – | – |
2021 Q2
11 quarters
|
|
3228
Rent the Runway
RENT
$58.4M
| $35 | ﹤0.01% |
5
| – | – |
2022 Q4
5 quarters
|
|
3229
DELISTED
CareMax, Inc. Class A Common Stock
CMAX
| $34 | ﹤0.01% |
7
+1
| +17% | +$8 |
2023 Q2
3 quarters
|
|
3230
Alzamend Neuro
ALZN
$6.37M
| – | – |
0
| – | – |
2023 Q4
1 quarter
|
|
3231
Consensus Cloud Solutions
CCSI
$654M
| $32 | ﹤0.01% |
2
-80
| -98% | -$1.43K |
2021 Q4
9 quarters
|
|
3232
Ribbon Communications
RBBN
$254M
| $32 | ﹤0.01% |
+10
| New | +$30 |
2024 Q1
0 quarters
|
|
|
RAD
3233
DELISTED
Rite Aid Corporation
RAD
| $32 | ﹤0.01% |
200
| – | – |
2023 Q4
1 quarter
|
|
3234
iShares MSCI Israel ETF
EIS
$859M
| – | – |
0
| – | – |
2024 Q1
0 quarters
|
|
3235
Americas Gold and Silver
USAS
$1.25B
| $29 | ﹤0.01% |
52
| – | – |
2022 Q1
8 quarters
|
|
3236
Hyliion Holdings
HYLN
$568M
| $25 | ﹤0.01% |
14
| – | – |
2020 Q3
14 quarters
|
|
3237
Microvast
MVST
$202M
| $25 | ﹤0.01% |
30
| – | – |
2021 Q1
12 quarters
|
|
3238
Avalo Therapeutics
AVTX
$655M
| $22 | ﹤0.01% |
+1
| New | +$5 |
2020 Q1
16 quarters
|
|
3239
OmniAb
OABI
$670M
| $22 | ﹤0.01% |
4
| – | – |
2022 Q4
5 quarters
|
|
3240
Orion Office REIT
ONL
$120M
| $21 | ﹤0.01% |
6
-309
| -98% | -$1.39K |
2022 Q1
8 quarters
|
|
3241
Recursion Pharmaceuticals
RXRX
$2.03B
| $20 | ﹤0.01% |
2
| – | – |
2023 Q2
3 quarters
|
|
3242
State Street SPDR S&P Bank ETF
KBE
$1.46B
| – | – |
0
| – | – |
2023 Q3
2 quarters
|
|
3243
DELISTED
Akoustis Technologies Inc
AKTS
| $18 | ﹤0.01% |
30
| – | – |
2020 Q4
13 quarters
|
|
3244
DELISTED
Doma Holdings, Inc.
DOMA
| $18 | ﹤0.01% |
4
| – | – |
2021 Q3
10 quarters
|
|
3245
Ellsworth Growth & Income Fund
ECF
$159M
| $17 | ﹤0.01% |
2
| – | – |
2021 Q1
12 quarters
|
|
3246
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
| – | – |
0
| – | – |
2021 Q1
12 quarters
|
|
3247
Embotelladora Andina Series B
AKO.B
$4.38B
| $15 | ﹤0.01% |
+1
| New | +$15 |
2024 Q1
0 quarters
|
|
|
NAVB
3248
DELISTED
Navidea Biopharmaceuticals Inc.
NAVB
| $13 | ﹤0.01% |
350
| – | – |
2020 Q1
16 quarters
|
|
3249
DELISTED
Enhabit
EHAB
| $12 | ﹤0.01% |
1
| – | – |
2022 Q3
6 quarters
|
|
|
AAGR
3250
DELISTED
African Agriculture Holdings Inc
AAGR
| $12 | ﹤0.01% |
30
| – | – |
2022 Q1
8 quarters
|
|
Similar funds
Parallel Advisors's Q1 2024 Portfolio in Review
As of Q1 2024, Parallel Advisors held 3,484 positions worth $3.69B, up 9.5% from $3.37B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Parallel Advisors's Q1 2024 filing shows 163 new, 1,467 increased, 807 reduced and 181 closed positions. Its largest new stake was Janus Henderson Mortgage-Backed Securities ETF: 338,790 shares worth $15.3M. The largest sale was iShares Core S&P Total US Stock Market ETF, an estimated $43.6M.
By sector, the portfolio is most concentrated in Miscellaneous at 49% of assets, down from 49% a quarter earlier, followed by Technology and Healthcare.
- Parallel Advisors's largest Q1 2024 buy was Janus Henderson Mortgage-Backed Securities ETF: 338,790 shares worth $15.3M.
- Parallel Advisors added most to Invesco S&P 500 Equal Weight ETF in Q1 2024, an estimated $50.7M increase.
- Parallel Advisors's biggest Q1 2024 reduction was iShares Core S&P Total US Stock Market ETF, cutting an estimated $43.6M.
- Parallel Advisors fully exited Lions Gate Entertainment Corp. Class B Non-Voting Shares in Q1 2024, selling an estimated $335K.
- Parallel Advisors's ten largest holdings make up 35% of its $3.69B portfolio in Q1 2024.
- Parallel Advisors opened 163 new positions and closed 181 in Q1 2024.
- Parallel Advisors's portfolio value rose 9.5% quarter-over-quarter to $3.69B.
Based on Parallel Advisors's 13F filing for Q1 2024, filed 6 May 2024.